Dendritic Cell Immunotherapy helps treat cancer




Cancer has been a nemesis for medical researchers for years and is one of the toughest and most resilient diseases encountered till date.From the day it was first diagnosed to present day when lifestyle-related attributes make us increasingly susceptible to contracting cancer, the battle had almost always been onesided, with cancer gaining the upper hand. The advent of modern medicine helps one overcome the disease with substantial success by employing a host of treatments but there was hardly any reliable and painless way for a patient to remit.Traditional courses of cancer treatment comprising chemotherapy and radiation are associated with side-effects like loss of appetite and hair, insomnia, severe discomfort and most of all, mental trauma and uncertainty .
With medical science heralding a new era in cancer treatment, Denvax Therapy has come as a breather for patients across the globe. Subject studies prove beyond doubt that cancer involves a defective immune system and unless this is repaired from within, even sustained efforts won't yield desired levels of success while treatment.Dendritic cell immunotherapy addresses this problem, serving to strengthen and rehabilitate patients' immune system. Injecting accessory cells, taken from a patient's white blood cells, developed in-vitro and trained to specifically target malignant cells in the body , Denvax Therapy proves to be the most bang-on approach to cancer combat, targeting micrometastases throughout. This customised immunotherapy has significant advantages over prescribed immunity-enhancing methods, since cells are taken from the patient's body itself and respond to body-specific requirements.

Dr Jamal A Khan is credited with bringing Denvax Therapy to India to benefit cancer patients. Years of unrelenting and unidirectional efforts by him have resulted in Dendritic Cell Therapy being established, accepted and welcomed by patients for managing cancer. This is evident from several accounts of his patients put on Dendritic Cell Therapy .

Case 1: A young woman with stage IV , inoperable breast cancer, a strong aversion to chemotherapy and back pain, opted for Dendritic Cell Therapy . After three doses of Denvax, she was convinced for oral chemotherapy .Six months of treatment resulted in visibly increased weight and appetite, with the cancer substantially contained. The tumour was operated, she could return to her profession and has been diseasefree for two years.

Case 2: A middle-aged woman, diagnosed with cervical cancer, suffered severe pain and had a poor appetite. Several rounds of radiation and chemotherapy administered offered minimal relief after which Denvax was added as palliative therapy . Six doses of Denvax eliminated the need of painkillers, increased appetite significantly and she has completed six years with almost no visible symptoms of the disease.

Where: 3, Vaibhav Building, SV Road, Vile Parle (W), 022-60601070.

Dr Khan also has clinics in Delhi, Kolkata and Ahmedabad.

Call: 18001231132.

http://www.youtube.com/watch?v=ZzL9jIM_K_0 http://www.youtube.com/watch?v=xuXujutxyvY http://www.denvax.in (*Procedures given are based on the expert's understanding of the said field)

No comments:

Post a Comment